Since its launch in 2006, our organization has experienced a rapid growth. So far, 60 research consortia have been formed, combining 31 universities, their affiliated medical centers and knowledge institutes and 48 industrial partners including global pharmaceutical companies and small and medium-sized enterprises (SMEs). These 60 consortia form the core of TI Pharma’s Strategic Research Program: high quality science, addressing serious diseases confronting the modern world.